Norwegian Royals

Mette-Marit leaves hospital smiling

The Crown Princess left the hospital after two and a half hours alongside Crown Prince Haakon and Princess Ingrid Alexandra, showing no outward sign of illness beyond the supplemental oxygen she relied on. The palace has not commented.

June 4, 2026 | SOURCES

Photo of Crown Princess Mette-Marit

Photo of Mette-Marit from an earlier occasion. Photo: Magnus Buer / Nordic Innovation, CC BY 2.0


Appears to have been scheduled

Crown Princess Mette-Marit, Crown Prince Haakon and Princess Ingrid Alexandra left Rikshospitalet on Thursday afternoon after about two and a half hours, all three appearing relaxed and smiling. The Crown Princess showed no outward signs of her illness beyond a nasal oxygen tube, with the equipment carried in a backpack. The Royal Court has issued no statement about the visit, which appears to have been planned.

At the hospital

Crown Princess Mette-Marit was driven to Rikshospitalet in Oslo earlier on Thursday. The family left the Skaugum residence at around 13:49 and arrived at the hospital shortly after 14:10, with Princess Ingrid Alexandra at the wheel and the Crown Princess in the passenger seat. A vehicle from the Police Security Service (PST) followed.

Both Princess Ingrid Alexandra and Crown Prince Haakon travelled home from abroad to be with the Crown Princess. Princess Ingrid Alexandra had landed in Norway on Wednesday, while Crown Prince Haakon returned on Thursday morning after cutting short an official visit to Japan. The Royal Court had previously signaled that the Princess would return home from her studies in Australia to be with her mother.

Background: a worsening lung disease

Mette-Marit publicly disclosed in 2018 that she had been diagnosed with chronic pulmonary fibrosis, a condition in which healthy lung tissue is gradually replaced by scar tissue, making the lungs stiffer and steadily reducing their ability to transfer oxygen to the blood. The disease cannot be cured and typically worsens over time, often in steps.

The Crown Princess's condition deteriorated markedly during 2025. On 19 December 2025, the Royal Court issued a press release confirming that her doctors had begun preparing for a possible lung transplant, and the Crown Princess spoke about her situation in NRK's year-end programme Året med kongefamilien. Her lung physician, Dr Are Martin Holm — a consultant and head of the lung department at Rikshospitalet — addressed the press the same day, describing pulmonary fibrosis as a disease that worsens over time and can be fatal.

The 52-year-old has appeared at only a small number of official engagements since the deterioration became public, and earlier in the autumn she completed a month of pulmonary rehabilitation at Cathinka Guldbergs Sykehus in Jessheim. Speaking to the press in early June 2026, Crown Prince Haakon described his wife's situation as medically serious and said she had grown somewhat weaker recently.

Lung transplantation in Norway

Rikshospitalet, part of Oslo University Hospital (OUS), is the only hospital in Norway that performs lung transplants. Around 30 are carried out each year; OUS figures cited in Norwegian media put the 2025 total at 36. For comparison, roughly 250 kidney transplants are performed annually. According to those figures, about two-thirds of the lung transplants in 2025 were for patients with pulmonary fibrosis. The number of operations is limited primarily by the availability of donor organs.

A patient is placed on the waiting list only once their expected survival without a transplant is estimated at one to two years. It is not a numbered queue in which patients simply move up: when a donor lung becomes available, the best-matched and sickest suitable patient is prioritised. Dr Holm has previously stressed that the Crown Princess would receive no preferential treatment.

Specialists quoted in Norwegian media describe the typical wait as somewhere between roughly five months and a year, though a well-matched organ can appear sooner — and once a match is found, the operation becomes a matter of hours. A lung transplant is a major procedure that carries significant risk, and recipients must take strong immunosuppressant drugs for the rest of their lives. Clinicians describe it as a life-saving intervention rather than a palliative one, with more than an 80 per cent chance that a patient survives at least five years after surgery.

RELATED ARTICLES

SOURCES

S&P Norwegian Royals